Evidence map›Paper›PMID 35661373›Full record

ArticleJournal of fish diseases2022

Resistance to Saprolegnia parasitica infection: A heritable trait in Atlantic salmon.

Ehab Misk, Serap Gonen, Amber F Garber

Open access · hybridAbstract read
In one paragraph

Article in Journal of fish diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ehab MiskAquatic Biosciences, Huntsman Marine Science Centre, Saint Andrews, New Brunswick, Canada.ORCID https://orcid.org/0000-0003-1125-5810
Serap GonenMowi Genetics, Mowi, Bergen, Norway.ORCID https://orcid.org/0000-0002-3937-6473
Amber F GarberAquatic Biosciences, Huntsman Marine Science Centre, Saint Andrews, New Brunswick, Canada.ORCID https://orcid.org/0000-0001-5088-2185
Huntsman Marine Science Centre · CAMowi (Norway) · NO

Funding

Atlantic Canada Opportunities Agency Atlantic Innovation FundNew Brunswick Innovation Foundation New Brunswick Innovation Research Chair InitiativeNew Brunswick Innovation Foundation Research Innovation FundNorthern Harvest Sea Farms Ltd/Mowi Canada East
6 · The paper itself

Abstract

A controlled Saprolegnia parasitica infection model was used to challenge 1158 fish representing 105 pedigreed Atlantic salmon families to evaluate the possibility of selecting for Saprolegnia resistance in a commercial breeding programme. Fish were infected in five study tanks and observed for 40 days post-infection for lesion score and survival. Survival analysis of the top 10 resistant and bottom 10 susceptible families indicated that the hazard of dying following Saprolegnia infection was 1509% higher in susceptible families. In all fish, a 10 g increase in weight correlated with a 7.8% increase in the hazard of dying while sex did not affect mortality. Resistance to Saprolegnia was estimated to have a heritability of 0.25, indicating that selection is possible. Genetic and phenotypic correlations indicated that the 11-point scoring system, developed in this study to quantify Saprolegnia infection severity, had a high negative correlation with survival as days to mortality at ≥-0.922(±0.005), suggesting that the scoring method could help assess lesion development in studies where mortality is not the primary biological endpoint.

Indexed as

Fish DiseasesInfectionsSalmo salarSaprolegniaAnimalschallengefamilygenetic selectionlesion scoringSaint John RiverSaprolegnia parasitica

Identifiers

PMID35661373
PMCPMC9544413
OpenAlexW4281949788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.